Details, Fiction and Ponsegromab
These trials confirmed clinically sizeable pharmacokinetic interactions [7] characterised by a minimize from the clearance of the anticancer drug and for this reason elevated exposure. The interpretation of subsequent phase II and III clinical trials was difficult because it was not possible to administer the same dose of chemotherapy within the pr